Tissue Kallikrein Prevents Restenosis After Stenting of Severe Atherosclerotic Stenosis of the Middle Cerebral Artery: A Randomized Controlled Trial

In-stent restenosis (ISR) following intracranial artery stenting affects long-term clinical outcome. This randomized controlled trial sought to identify the long-term efficacy of exogenous tissue kallikrein (TK) for preventing ISR after intracranial stenting of symptomatic middle cerebral artery (MC...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ruifeng, Zhang, Renliang, Yang, Fang, Lin, Min, Li, Min, Liu, Ling, Yin, Qin, Lin, Hang, Xiong, Yunyun, Liu, Wenhua, Fan, Xiaobing, Dai, Qiliang, Zhou, Lizhi, Lan, Wenya, Cao, Qinqin, Chen, Xin, Xu, Gelin, Liu, Xinfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753947/
https://www.ncbi.nlm.nih.gov/pubmed/26871851
http://dx.doi.org/10.1097/MD.0000000000002809

Ejemplares similares

Ejemplares similares